Who invested in Bonum Therapeutics?
Bonum Therapeutics's investors include Vivo Capital and Digitalis Ventures.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$120Mraised across 2 rounds since 2022, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $45M sold, first sale Nov 2022
From Bonum Therapeutics's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Bonum Therapeutics's investors include Vivo Capital and Digitalis Ventures.
Bonum Therapeutics has raised $120M across 2 rounds since 2022.
Bonum Therapeutics's most recent round was a Venture of $27M in Apr 2026.
Bonum Therapeutics's largest round on record is $93M (Series A), in Nov 2022.
Bonum Therapeutics's first round on record, in Nov 2022, was backed by Vivo Capital and Digitalis Ventures.
Bonum Therapeutics's latest named round is a Venture, in Apr 2026.
Bonum Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.